Diagnosis of graft coronary artery disease

Current Opinion in Cardiology

Volumn 22, Issue 2, 2007, Pages 139-145

  Kass, Malek ^a   Allan, Rebecca ^a   Haddad, Haissam ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cardiac transplantation; Graft coronary artery disease; Intravascular ultrasound

Indexed keywords

DOBUTAMINE;

ANGIOCARDIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FALSE POSITIVE RESULT; GRAFT DYSFUNCTION; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; INVASIVE PROCEDURE; LABORATORY TEST; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; EXERCISE TEST; GRAFT OCCLUSION, VASCULAR; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; POPULATION SURVEILLANCE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33846856675     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328021066b     Document Type: Review

References (70)

1. Billingham ME. Histopathology of graft coronary artery disease. J Heart Lung Transplant 1992; 11 (3 Pt 2):S38-S44.
2. Wong PM, Piamsomboon C, Mathur A, et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol 1998; 82:239-241.
3. Dempsey SJ, D'Amico C, Weintraub WS, et al. Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol 2000; 12:311-315.
4. Simpson L, Lee EK, Hott BJ, et al. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant 2005; 24:1211-1217.
5. Halle AA 3rd, DiSciascio G, Massin EK, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995; 26:120-128.
6. Tanaka K, Li H, Curran PJ, et al. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol 2006; 97:1192-1197.
7. Estorch M, Camprecios M, Flotats A, et al. Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging. J Nucl Med 1999; 40:911-916.
8. Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 1998; 66:507-515.
9. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333:621-627.
10. Mehra MR, Uber PA, Vivekananthan K, et al. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol 2002; 40:1609-1614.
11. Kass M, Haddad H. Cardiac allograft vasculopathy: pathology, prevention and treatment. Curr Opin Cardiol 2006; 21:132-137.
12. Gao SZ, Alderman EL, Schroeder JS, et al. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12:334-340.
13. Stork S, Behr TM, Birk M, et al. Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary? J Heart Lung Transplant 2006; 25:1103-1108. These data suggest routine echocardiogram, donor age, and loss of antithrombin III staining in right ventricular biopsy can predict who will develop GCAD and need coronary angiography.
14. Keogh AM, Valantine HA, Hunt SA, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 1992; 11:892-901.
15. Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995; 14 (6 Pt 2):S215-S220.
16. Kapadia SR, Ziada KM, L'Allier PL, et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multivessel imaging. J Heart Lung Transplant 2000; 19:167-172.
17. St Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85:979-987.
18. Mehra MR, Ventura HO, Stapleton DD, et al. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant 1995; 14:632-639.
19. Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005; 45:1532-1537.
20. Fyfe AI, Rothenberg LS, DeBeer FC, et al. Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997; 96:2914-2919.
21. Hognestad A, Endresen K, Wergeland R, et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 2003; 42:477-482.
22. Pethig K, Heublein B, Kutschka I, Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy. Circulation 2000; 102 (19 Suppl 3):III233-III236.
23. Pethig K, Heublein B, Wahlers T, et al. Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia. J Heart Lung Transplant 2004; 23:61-66.
24. Eisenberg MS, Chen HJ, Warshofsky MK, et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 2000; 102:2100-2104.
25. Lindahl B, Venge P, Wallentin L, for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997; 29:43-48.
26. Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112:3088-3096.
27. King DA, Codish S, Novack V, et al. The role of cardiac troponin I as a prognosticator in critically ill medical patients: a prospective observational cohort study. Crit Care 2005; 9:R390-R395.
28. Miller WL, Edwards BS, Kremers WK, et al. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant 2005; 24:2075-2078.
29. Smart FW, Ballantyne CM, Cocanougher B, et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67:243-247.
30. Ehrman JK, Keteyian SJ, Levine AB, et al. Exercise stress tests after cardiac transplantation. Am J Cardiol 1993; 71:1372-1373.
31. Fang JC, Rocco T, Jarcho J, et al. Noninvasive assessment of transplant-associated arteriosclerosis. Am Heart J 1998; 135 (6 Pt 1):980-987.
32. Redonnet M, Derumeaux G, Mouton-Schleifer D, et al. Noninvasive detection of cardiac graft vascular disease. Transplant Proc 1995; 27:2530-2531.
33. Ciliberto GR, Mangiavacchi M, Banfi F, et al. Coronary artery disease after heart transplantation: noninvasive evaluation with exercise thallium scintigraphy. Eur Heart J 1993; 14:226-229.
34. Rodney RA, Johnson LL, Blood DK, Barr ML. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi. J Heart Lung Transplant 1994; 13:173-180.
35. Smart FW, Grinstead WC, Cocanougher B, et al. Detection of transplant arteriopathy: does exercise thallium scintigraphy improve noninvasive diagnostic capabilities? Transplant Proc 1991; 23 (1 Pt 2):1189-1192.
36. Ambrosi P, Habib G, Kreitman B, et al. Thallium perfusion and myocardial hypertrophy in transplanted heart recipients with normal or near-normal coronary arteriograms. Eur Heart J 1994; 15:1119-1123.
37. Howarth DM, Forstrom LA, Samudrala V, et al. Evaluation of 201Tl SPECT myocardial perfusion imaging in the detection of coronary artery disease after orthotopic heart transplantation. Nucl Med Commun 1996; 17:105-113.
38. Wu YW, Yen RF, Lee CM, et al. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation. J Heart Lung Transplant 2005; 24:544-550.
39. Ciliberto GR, Ruffini L, Mangiavacchi M, et al. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation. Eur Heart J 2001; 22:964-971.
40. Carlsen J, Toft JC, Mortensen SA, et al. Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients. J Heart Lung Transplant 2000; 19:873-878.
41. Elhendy A, Sozzi FB, van Domburg RT, et al. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis. J Heart Lung Transplant 2000; 19:360-366.
42. Hacker M, Tausig A, Romuller B, et al. Dobutamine myocardial scintigraphy for the prediction of cardiac events after heart transplantation. Nucl Med Commun 2005; 26:607-612.
43. Elhendy A, van Domburg RT, Vantrimpont P, et al. Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging. Am J Cardiol 2002; 89:964-968.
44. Ciliberto GR, Massa D, Mangiavacchi M, et al. High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation. Eur Heart J 1993; 14:48-52.
45. Collings CA, Pinto FJ, Valantine HA, et al. Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography. J Heart Lung Transplant 1994; 13:604-613.
46. Cohn JM, Wilensky RL, O'Donnell JA, et al. Exercise echocardiography, angiography, and intracoronary ultrasound after cardiac transplantation. Am J Cardiol 1996; 77:1216-1219.
47. Akosah KO, Mohanty PK, Funai JT, et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 1994; 13:1024-1038.
48. Herregods MC, Anastassiou I, Van Cleemput J, et al. Dobutamine stress echocardiography after heart transplantation. J Heart Lung Transplant 1994; 13:1039-1044.
49. Derumeaux G, Redonnet M, Mouton-Schleifer D, et al. Dobutamine stress echocardiography in orthotopic heart transplant recipients. J Am Coll Cardiol 1995; 25:1665-1672.
50. Spes CH, Mudra H, Schnaack SD, et al. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol 1996; 78:168-174.
51. Derumeaux G, Redonnet M, Soyer R, et al. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography. J Heart Lung Transplant 1998; 17:259-267.
52. Spes CH, Klauss V, Mudra H, et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation 1999; 100:509-515.
53. Jackson PA, Akosah KO, Kirchberg DJ, et al. Relationship between dobutamine-induced regional wall motion abnormalities and coronary flow reserve in heart transplant patients without angiographic coronary artery disease. J Heart Lung Transplant 2002; 21:1080-1089.
54. Bartunek J, Marwick TH, Rodrigues AC, et al. Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 1996; 27:1429-1436.
55. Akosah K, Olsovsky M, Mohanty PK. Dobutamine stress-induced angina in patients with denervated cardiac transplants: clinical and angiographic correlates. Chest 1995; 108:695-700.
56. Bacal F, Moreira L, Souza G, et al. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 2004; 23:1238-1244.
57. Rodrigues AC, Bacal F, Medeiros CC, et al. Noninvasive detection of coronary allograft vasculopathy by myocardial contrast echocardiography. J Am Soc Echocardiogr 2005; 18:116-121.
58. Hau WK. Fractional flow reserve and complex coronary pathologic conditions. Eur Heart J 2004; 25:723-727.
59. Tona F, Caforio AL, Montisci R, et al. Coronary flow reserve by contrast-enhanced echocardiography: a new noninvasive diagnostic tool for cardiac allograft vasculopathy. Am J Transplant 2006; 6 (5 Pt 1):998-1003. This study describes a new noninvasive diagnostic tool for GCAD.
60. Tona F, Caforio AL, Montisci R, et al. Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 2006; 114 (1 Suppl):I49-55.
61. Allen-Auerbach M, Schoder H, Johnson J, et al. Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. J Heart Lung Transplant 1999; 18:211-219.
62. Fyfe DA, Ketchum D, Lewis R, et al. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with preterminal cardiac graft failure after heart transplantation. J Heart Lung Transplant 2006; 25:510-517.
63. Preumont N, Berkenboom G, Vachiery J, et al. Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. J Heart Lung Transplant 2000; 19:538-545.
64. Chow BJ, Hoffmann U, Nieman K. Computed tomographic coronary angiography: an alternative to invasive coronary angiography. Can J Cardiol 2005; 21:933-940.
65. Romeo G, Houyel L, Angel CY, et al. Coronary stenosis detection by 16-slice computed tomography in heart transplant patients: comparison with conventional angiography and impact on clinical management. J Am Coll Cardiol 2005; 45:1826-1831.
66. Sigurdsson G, Carrascosa P, Yamani MH, et al. Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multi-segment reconstruction. J Am Coll Cardiol 2006; 48:772-778. This article describes a new noninvasive diagnostic tool for GCAD by using multidetector CT scanning.
67. Knollmann FD, Bocksch W, Spiegelsberger S, et al. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation 2000; 101:2078-2082.
68. Ratliff NB 3rd, Jorgensen CR, Gobel FL, et al. Lack of usefulness of electron beam computed tomography for detecting coronary allograft vasculopathy. Am J Cardiol 2004; 94:202-206.
69. Almenar L, Igual B, Martinez-Dolz L, et al. Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection. Transplant Proc 2003; 35:1962-1964.
70. Caus T, Kober F, Marin P, et al. Noninvasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging. Eur J Cardiothorac Surg 2006; 29:45-49.